Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
5(19%)
Results Posted
36%(4 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
4
15%
Ph not_applicable
1
4%
Ph phase_3
4
15%
Ph phase_2
7
26%
Ph phase_4
5
19%
Ph early_phase_1
1
4%

Phase Distribution

5

Early Stage

7

Mid Stage

9

Late Stage

Phase Distribution22 total trials
Early Phase 1First-in-human
1(4.5%)
Phase 1Safety & dosage
4(18.2%)
Phase 2Efficacy & side effects
7(31.8%)
Phase 3Large-scale testing
4(18.2%)
Phase 4Post-market surveillance
5(22.7%)
N/ANon-phased studies
1(4.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

11 of 14 finished

Non-Completion Rate

21.4%

3 ended early

Currently Active

5

trials recruiting

Total Trials

27

all time

Status Distribution
Active(6)
Completed(11)
Terminated(3)
Other(7)

Detailed Status

Completed11
unknown7
Active, not recruiting3
Recruiting2
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
5
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.5%)
Phase 14 (18.2%)
Phase 27 (31.8%)
Phase 34 (18.2%)
Phase 45 (22.7%)
N/A1 (4.5%)

Trials by Status

terminated14%
active_not_recruiting311%
not_yet_recruiting14%
completed1141%
recruiting27%
unknown726%
withdrawn27%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT06190509Phase 1

Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

Active Not Recruiting
NCT06128915Phase 4

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

Recruiting
NCT04948619Phase 2

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Recruiting
NCT06837116Early Phase 1

Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers

Completed
NCT01022749Phase 3

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

Completed
NCT07158190

Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

Active Not Recruiting
NCT06955728Phase 4

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Not Yet Recruiting
NCT06882070

ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage

Completed
NCT03391921Phase 4

Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)

Active Not Recruiting
NCT05986981Phase 2

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Unknown
NCT01299480Phase 2

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Completed
NCT04107961Phase 2

A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)

Withdrawn
NCT04553016Phase 1

A Study to Test Three Experimental HIV Vaccines in Healthy Adults.

Unknown
NCT05331742

Comparison of Clinical Outcome Among Vaccinated and Unvaccinated Coronavirus Disease Patients in Critical Care Unit.

Unknown
NCT05298800Phase 4

Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23

Unknown
NCT04618796

Effect of COVID-19 Pandemic on Vaccination Compliance

Unknown
NCT01896869Phase 2

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Completed
NCT04330014

Factor Affecting Childhood Immunization Among Childern.

Unknown
NCT03000543Not Applicable

Novel Isotope Dilution Technique to Assess Vitamin A Status

Completed
NCT02935192Phase 3

Phase 3 Trial of Serbian Seasonal Influenza Vaccine

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
27